Abbott Laboratories, commonly referred to as Abbott, is a global healthcare company headquartered in China (CN). Founded in 1888, Abbott has established itself as a leader in the pharmaceutical and medical device industries, with a strong presence in North America, Europe, and Asia. The company is renowned for its innovative products across various sectors, including diagnostics, nutrition, and branded generic pharmaceuticals. Abbott's core offerings include advanced diagnostic tools, nutritional products, and medical devices, each designed to enhance patient care and improve health outcomes. Notable achievements include the development of groundbreaking technologies in glucose monitoring and rapid diagnostics, positioning Abbott as a trusted name in healthcare. With a commitment to innovation and quality, Abbott continues to shape the future of health and wellness globally.
How does Abbott's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Abbott's score of 15 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abbott, headquartered in China (CN), currently does not provide specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not outlined any formal reduction targets or climate pledges. Without emissions data or defined commitments, it is challenging to assess Abbott's climate impact or initiatives. The absence of this information suggests a need for further transparency regarding their environmental strategies and performance in relation to carbon emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abbott has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
